Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.12 +0.01 (+0.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Common Stock Issued (2020 - 2026)

Updated

Analysis

Taysha Gene Therapies (TSHA) Common Stock Issued (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 359.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 9.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Taysha Gene Therapies 1.52 Bn 173.19 Mn - 441,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 441,000.00
Mar 31, 2026 692,000.00
Dec 31, 2025 1.25 Mn
Sep 30, 2025 281,000.00
Mar 31, 2025 75,000.00
Dec 31, 2024 -40,000.00
Sep 30, 2024 103,000.00
Mar 31, 2024 26,000.00
Sep 30, 2023 518,000.00
Mar 31, 2023 50,000.00
Dec 31, 2022 -11.64 Mn
Sep 30, 2022 -68,000.00
Jun 30, 2022 11.68 Mn
Mar 31, 2022 277,000.00
Dec 31, 2020 -1.31 Mn
API Access

Taysha Gene Therapies Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=TSHA&period=max&api_key=YOUR_API_KEY